(Image source from: Businessinsider.in)

Oxford Vaccine to Begin the Third Phase of Clinical Trials in India:- There are several vaccines that are undergoing clinical trials in the country which are in various phases. The Union Ministry of Health and Family Welfare said that the third phase of the trials of the Oxford vaccine will begin this week. Dr VK Paul held a press conference who is the head of the national task force for coronavirus in the country. Dr VK Paul said that the results of the tests are quite encouraging till date. The other two vaccines which are conducting trials are in the first and second phase of pre-clinical trials. Their names are not revealed as they are in their testing phase. Oxford University's vaccine is named ChAdOx1 and is manufactured by Serum Institute of India (SII), Pune.

Bharat Biotech’s vaccination is named AstraZeneca and is jointly developed by the Indian Council of Medical Research along with Bharat Biotech. The third vaccine is ZycovD by Zydus Cadila. Serum Institute of India finalized ten centers across the country to conduct the human trials. Oxford vaccine will begin its third phase of trials in Pune and Mumbai along with Ahmedabad. The vaccine will be given to 1600 people in this phase and they are finalized recently. The National Expert Group on Vaccine Administration met five manufacturers of coronavirus vaccination in the country to review their stages of the trials that are conducted on humans.

As per the reports from the National Expert Group on Vaccine Administration, the people who are never infected with coronavirus will be the first ones to get the dose of vaccine in the country. The people who are tested positive with coronavirus and those who developed antibodies will not be given the vaccination doses initially.